These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 7579492)

  • 21. Cyclophosphamide, methotrexate and fluorouracil (CMF) versus hormonal ablation with leuprorelin acetate as adjuvant treatment of node-positive, premenopausal breast cancer patients: preliminary results of the TABLE-study (Takeda Adjuvant Breast cancer study with Leuprorelin Acetate).
    Schmid P; Untch M; Wallwiener D; Kossé V; Bondar G; Vassiljev L; Tarutinov V; Kienle E; Lüftner D; Possinger K;
    Anticancer Res; 2002; 22(4):2325-32. PubMed ID: 12174922
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lack of the relationship between menstrual status and timing of surgery in survival of premenopausal patients with breast cancer.
    Tsuchiya A; Furukawa H; Kanno M; Kimijima I; Abe R
    Fukushima J Med Sci; 1996 Dec; 42(1-2):11-6. PubMed ID: 9127965
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlation of menstrual cycle at time of breast cancer surgery to disease-free and overall survival.
    Vanek VW; Kadivar TF; Bourguet CC
    South Med J; 1997 Aug; 90(8):780-8. PubMed ID: 9258303
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Effect of Menstrual Cycle Phase on the Prognostic Factors in Patients with Premenopausal Breast Tumors.
    Kundaktepe BP; Durmus S; Papila C; Velidedeoglu M; Gelisgen R; Uzun H
    Chirurgia (Bucur); 2021; 116(2):209-213. PubMed ID: 33950817
    [No Abstract]   [Full Text] [Related]  

  • 25. Dose-response effect of adjuvant cyclophosphamide, methotrexate, 5-fluorouracil (CMF) in node-positive breast cancer. International Breast Cancer Study Group.
    Colleoni M; Price K; Castiglione-Gertsch M; Goldhirsch A; Coates A; Lindtner J; Collins J; Gelber RD; Thürlimann B; Rudenstam CM
    Eur J Cancer; 1998 Oct; 34(11):1693-700. PubMed ID: 9893654
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adjuvant cyclophosphamide, methotrexate, and fluorouracil in premonopausal patients with node-positive breast cancer: indirect comparison of dose and schedule in DBCG trials 77, 82, and 89.
    Ejlertsen B; Mouridsen HT; Jensen MB
    Acta Oncol; 2008; 47(4):662-71. PubMed ID: 18465334
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic effect of menstrual cycle on timing of surgery in premenopausal breast cancer patients.
    Liu Y; Wang Y; Zhou L; Yin K; Yin W; Lu J
    Am J Surg; 2015 Sep; 210(3):506-11. PubMed ID: 26066864
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Menstrual timing of treatment for breast cancer.
    Senie RT; Kinne DW
    J Natl Cancer Inst Monogr; 1994; (16):85-90. PubMed ID: 7999475
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Timing of surgery in relation to menstrual cycle does not predict the prognosis in primary breast cancer. Danish Breast Cancer Cooperative Group.
    Kroman N; Højgaard A; Andersen KW; Graversen HP; Afzelius P; Lokdam A; Juul C; Hoffmann J; Bentzon N; Mouridsen HT
    Eur J Surg Oncol; 1994 Aug; 20(4):430-5. PubMed ID: 8076704
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Timing of breast cancer surgery during the luteal menstrual phase may improve prognosis.
    Lemon HM; Rodriguez-Sierra JF
    Nebr Med J; 1996 Mar; 81(3):73-8. PubMed ID: 8907825
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Timing of breast cancer surgery during the luteal menstrual phase may improve prognosis.
    Lemon HM; Rodriguez-Sierra JF
    Nebr Med J; 1996 Apr; 81(4):110-5. PubMed ID: 8628449
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Timing of surgery for primary breast cancer with regard to the menstrual phase and prognosis.
    Jatoi I
    Breast Cancer Res Treat; 1998; 52(1-3):217-25. PubMed ID: 10066084
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of the gonadotropin-releasing hormone analogue triptorelin on the occurrence of chemotherapy-induced early menopause in premenopausal women with breast cancer: a randomized trial.
    Del Mastro L; Boni L; Michelotti A; Gamucci T; Olmeo N; Gori S; Giordano M; Garrone O; Pronzato P; Bighin C; Levaggi A; Giraudi S; Cresti N; Magnolfi E; Scotto T; Vecchio C; Venturini M
    JAMA; 2011 Jul; 306(3):269-76. PubMed ID: 21771987
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial.
    Overgaard M; Hansen PS; Overgaard J; Rose C; Andersson M; Bach F; Kjaer M; Gadeberg CC; Mouridsen HT; Jensen MB; Zedeler K
    N Engl J Med; 1997 Oct; 337(14):949-55. PubMed ID: 9395428
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Survival of premenopausal women with breast carcinoma: effects of menstrual timing of surgery.
    Harlap S; Zauber AG; Pollack DM; Tang J; Arena AE; Sternfels P; Borgen P; Norton L
    Cancer; 1998 Jul; 83(1):76-88. PubMed ID: 9655296
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic effect of timing of surgery during menstrual cycle in premenopausal breast-cancer patients. German Breast Cancer Study Group.
    Sauerbrei W; Bastert G; Schmoor C
    Int J Cancer; 1994 Oct; 59(1):149-50. PubMed ID: 7927895
    [No Abstract]   [Full Text] [Related]  

  • 37. Incidence of chemotherapy-induced amenorrhea depending on the timing of treatment by menstrual cycle phase in women with early breast cancer.
    Di Cosimo S; Alimonti A; Ferretti G; Sperduti I; Carlini P; Papaldo P; Fabi A; Gelibter A; Ciccarese M; Giannarelli D; Mandalà M; Milella M; Ruggeri EM; Cognetti F
    Ann Oncol; 2004 Jul; 15(7):1065-71. PubMed ID: 15205200
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adjuvant treatment of node-positive breast cancer with cyclophosphamide, doxorubicin, fluorouracil, and vincristine versus cyclophosphamide, methotrexate, and fluorouracil: final report after a 16-year median follow-up duration.
    Misset JL; di Palma M; Delgado M; Plagne R; Chollet P; Fumoleau P; Le Mevel B; Belpomme D; Guerrin J; Fargeot P; Metz R; Ithzaki M; Hill C; Mathé G
    J Clin Oncol; 1996 Apr; 14(4):1136-45. PubMed ID: 8648368
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic effect of timing of operation in relation to menstrual phase of breast cancer patient--fact or fallacy.
    Holli K; Isola J; Hakama M
    Br J Cancer; 1995 Jan; 71(1):124-7. PubMed ID: 7819026
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Randomized trial of intensive cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil in premenopausal women with node-positive breast cancer. National Cancer Institute of Canada Clinical Trials Group.
    Levine MN; Bramwell VH; Pritchard KI; Norris BD; Shepherd LE; Abu-Zahra H; Findlay B; Warr D; Bowman D; Myles J; Arnold A; Vandenberg T; MacKenzie R; Robert J; Ottaway J; Burnell M; Williams CK; Tu D
    J Clin Oncol; 1998 Aug; 16(8):2651-8. PubMed ID: 9704715
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.